Jeff Siegel recently released a presentation on the Angel Publishing website about an “Atomic Disruption” that could make investors 100X gains in the years ahead.
Jeff refers to this “disruption” as “Helix-Scaling,” and says it will be “the most important megatrend of the next 20 years.” He also says there’s one Boston-based company at the center of it, which he reveals in a report you get with a Green Chip Stocks subscription.
What is Helix-Scaling? What stock is Jeff Siegel teasing? And is the presentation legit?
These are some of the questions I’ll shed some light on in this post.
Let’s start by looking at Jeff’s overall thesis. Then, I’ll show you what stock I think he’s interested in and show you what Green Chip Stocks is all about to help you decide if it’s worth it or not.
Overview of Jeff Siegel’s Helix-Scaling Thesis
First of all, what is Helix-Scaling?
Well, as far as I know, it’s not the name of an actual technology.
Instead, Helix-Scaling is a term Jeff Siegel uses to more or less describe the technology behind “reprogramming DNA” to make innovative products. Specifically, he talks about taking the DNA found in nature and programming it.
Why would you do that? From what I understand, to improve existing products, create new ones, and generally make the world a better place.
How does Helix-Scaling work?
During the presentation, Jeff talks about how, when you plant an apple seed, it “assembles itself out of thin air” and says that the Helix-Scaling uses similar capabilities.
All these capabilities — self-assembly, self-repair, CO2 reduction, manufacturing at an atomic level…
Helix-Scaling lets us use them. We don’t have to invent these things ourselves — we get to benefit from what nature already does.Source: https://secure.angelpub.com/o/web/366094
Jeff doesn’t mention this specifically, but I believe the technical term for what Jeff talks about in the presentation is synthetic biology because it relates to much of what he describes.
What is synthetic biology?
According to the Wikipedia article I just linked to:
Synthetic biology (SynBio) is a multidisciplinary area of research that seeks to create new biological parts, devices, and systems, or to redesign systems that are already found in nature.Source: https://en.wikipedia.org/wiki/Synthetic_biology
I’m not a scientist, so the specifics on what synthetic biology is and how it works is beyond me, but I did manage to find a helpful Youtube video that explains it in about three minutes:
What sort of products can “Helix-Scaling” produce?
According to Jeff Siegel, Helix-Scaling (AKA synthetic biology) is responsible for some remarkable innovations across various industries.
For example, he talks about how foldable smartphones are made possible with the DNA of translucent plant parts, squid DNA is behind active camouflage, and insect DNA has made “extremely strong adhesives for almost-unbreakable glass” possible.
He also talked about glow-in-the-dark trees (bioluminescent algae DNA), lighter and tougher armor (spider silk DNA), and water-resistant building materials (fungus DNA).
All of this is very interesting, and if what Jeff’s saying is true, then this sort of technology could no doubt be massively disruptive over the coming years.
I haven’t checked all of Jeff Siegel’s claims, but based on my research, the examples he shares about how DNA can be “reprogrammed” to develop innovative products are real.
And according to Jeff, this technology “will disrupt the electronics, defense, construction, pharma, food, energy, and manufacturing industries.”
He also says “Helix-Scaling is expected to unlock $4 trillion in new wealth in as little as 10 years.”
That’s a bold claim.
And there’s no guarantee that will happen.
But that is what Jeff states in the presentation.
Why does he call it “Helix-Scaling?”
I can’t speak to the exact reason why Jeff Siegel calls it Helix-Scaling, but the term double helix is used to describe the structure of a DNA molecule, so my guess is it has something to do with that.
Jeff also talks about an “important catalyst behind Helix-Scaling’s mass adoption” in the presentation, which has to do with how DNA sequencing costs are lowering.
Specifically, he talks about how, in 1990, it cost $2.7 billion to sequence human DNA (whereas it now costs a couple of hundred dollars) and how this “affordability to decode the DNA of all kinds of organisms” is what’s making industrial Helix-Scaling economically possible.
And according to the presentation, the company Jeff Siegel’s interested in owns “more than 440 million proprietary gene sequences” and is speeding up the process of re-writing DNA.
As I’ve already told you, to make a cell do something new, about 1% of the DNA has to be rewritten.
But to get that 1% correct, it takes several hundred thousand, even a million different versions of that code until you get the right one.
This company speeds up that process with the help of proprietary design tools and sophisticated machine learning.
What company is Jeff bullish on?
Jeff doesn’t reveal his stock pick in the presentation. However, he does provide lots of clues, so I did some research, and in the next section, I’ll show you what I found.
What Is Jeff Siegel’s “Helix-Scaling” Stock Pick?
Based on the clues in the presentation, I believe Jeff Siegel’s “Helix-Scaling” stock pick is a company called Ginkgo Bioworks (DNA).
According to the company website, Ginkgo programs cells to “make everything from food to materials to therapeutics,” so they appear to be involved in the type of scientific innovation Jeff Siegel describes in the presentation. And it matches up with virtually all of Jeff’s clues.
Here’s a summary of the main clues he shares:
“This Boston-based company just went public, and today you have the brief chance to get in on the ground floor.”
“You can get started with a small stake of less than $25.”
“However, Moderna isn’t its only customer.”
“It also helps Roche create next-generation antibiotics…”
“Develops crops for Bayer that make their own fertilizer…”
“And assists Cronos Group — a 9,033% winner itself — in producing cannabinoids at industrial scale.”
“This company’s revenue is expected to soar from $150 million to $1 billion within the next three years.”
“As of today, it owns not 10 million… not 100 million… but more than 440 million proprietary gene sequences.”
There are numerous other clues, but these were enough to show it’s a match.
Here’s a quick breakdown of why:
- Ginkgo is a Boston-based company.
- It’s stock (ticker: DNA) is currently trading at around $9 per share (although I’m not sure why he mentioned $25 since that’s more than double).
- It has collaborated with all of the above-mentioned companies in different ways.
- According to techcrunch.com: “the company aimed to draw about $150 million in revenue in 2021, but the August earning call updated that total for the year to over $175 million.”
- Ginkgo claims to have over 440 million proprietary gene sequences.
Jeff Siegel also shared a quote from Harry Sloan in the presentation (which he said was about the firm he’s teasing), and it’s a match with the quote in this article about Ginkgo.
So, long story short, I can’t comment on whether or not it’s a good investment, but Ginkgo is a match based on the clues Jeff shares in the presentation.
Either way, if you want to know what company Jeff Siegel’s recommending and why you’d need to join Green Chip Stocks.
And the reason is that Jeff has put together a research report titled “Helix-Scaling: How to Tap Into $4 Trillion of New Wealth With One Stock,” which details his pick and the only way to access the report is to join Green Chip Stocks.
So let’s take a look at what this service is about and how it works.
How Does Green Chip Stocks Work?
Green Chip Stocks is an investment advisory service edited by Jeff Siegel and published by Angel Publishing focused on things like renewable energy, transportation, and agriculture.
According to the Angel Publishing website, the service approaches investments with the idea of doing well by doing good or socially responsible investing.
Jeff Siegel says he leverages his “elite network of contacts” to “exploit the green market’s most significant moves” before mainstream money does, and he shares his top stock picks with subscribers of the service.
How does the service work?
As a subscriber of Green Chip Stocks, you get access to a member’s website where Jeff shares his stock recommendations, research, and insights.
You also get access to a model portfolio to see all of Jeff’s current Green Chip Stocks recommendations, weekly updates on the portfolio, and some bonus research reports.
If you sign up through the presentation, there are two bonus reports. The first is “Helix-Scaling: How to Tap Into $4 Trillion of New Wealth With One Stock,” and the second is “The Future of ‘DNA Manufacturing,” which details a second company Jeff is interested in.
How much does it cost to get started?
The Green Chip Stocks service costs $99 for 12 months if you join through the “Helix-Scaling” presentation or $179 for two years. And according to the website, the service comes with a six-month money-back guarantee.
Is Jeff Siegel the Real Deal?
Jeff Siegel is the editor of Green Chip Stocks and several other Angel Publishing services, including Energy and Capital, Liberty Briefing, and Wealth Daily.
I first came across Jeff in a different presentation about SPV royalties, where he was talking about a different investment opportunity related to solar power.
As I explained in that post, Jeff first started working for Agora in 1994, traveled around the world, and then joined Angel Publishing in 2003.
According to his Angel Publishing profile, Jeff has over 30 years of experience as a professional investor, and based on what he says in the presentation; he’s recommended some great stocks over the years across a variety of industries.
I don’t know Jeff personally, nor do I have access to his entire track record, but he does seem to be a legitimate investment guru with a solid track record.
Jeff Siegel’s Helix-Scaling presentation centers around the possibilities around reprogramming DNA to develop innovative products that could change the world. And he believes Helix-Scaling could “unlock $4 trillion in new wealth” within 10 years, which is a bold prediction.
Overall, his presentation reminded me of what Adam O’Dell talked about during his Imperium Machine teaser, but Jeff seems to be interested in a different company.
As I pointed out earlier, I believe the company Jeff Siegel is bullish on appears to be Ginkgo Bioworks. However, I haven’t read his research report on Helix-Scaling; that’s simply my best guess based on the clues he shared in the presentation.
Whether or not Green Chip Stocks is worth joining is up to you, but it’s not a scam and could be worthwhile if you’re interested in learning about emerging tech and biotech companies. Especially if you’re interested in the “do well by doing good” philosophy the service embraces.
In any case, hopefully, what I’ve shared helps demystify the presentation a bit and if you’d like to share your thoughts on the presentation or service, feel free to comment below.